Nuveen, LLC Mirum Pharmaceuticals, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 654,722 shares of MIRM stock, worth $28.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
654,722Holding current value
$28.9 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
216Shares Held
54.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$290 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$202 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$143 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$123 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$115 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...